Christopher Peetz Mirum Pharmaceuticals, Inc. (MIRM) insider trading activity

Christopher Peetz is CHIEF EXECUTIVE OFFICER of Mirum Pharmaceuticals, Inc.. Currently has a direct ownership of 158,034 shares of MIRM, which is worth approximately $11.3 Million. The most recent transaction as insider was on Nov 24, 2021, when has been sold 7,000 shares (Common Stock) at a price of $14.4 per share, resulting in proceeds of $100,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 158K

13.99% 3M change

32.4% 12M change

Total Value Held $11.3 Million

Christopher Peetz Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 24 2021	BUY Open market or private purchase	$100,800 $14.4 p/Share	7,000 Added 19.98%	28,027 Common Stock
Oct 01 2021	SELL Open market or private sale	$70,723 $19.26 p/Share	3,672 Reduced 14.87%	21,027 Common Stock
Sep 29 2021	BUY Grant, award, or other acquisition	-	21,875 Added 46.97%	24,699 Common Stock
May 10 2021	BUY Grant, award, or other acquisition	$21,243 $14.62 p/Share	1,453 Added 33.97%	2,824 Common Stock
Nov 10 2020	BUY Grant, award, or other acquisition	$20,935 $15.27 p/Share	1,371 Added 50.0%	1,371 Common Stock

Also insider at

ALPN

ALPINE IMMUNE SCIENCES, INC. Healthcare

Director